Cerebrospinal fluid beta2-microglobulin: a study in controls and patients with metastatic and non-metastatic neurological diseases
- 1 April 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (4) , 387-391
- https://doi.org/10.1016/0277-5379(86)90103-3
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Detection of central nervous system metastasis with cerebrospinal fluid beta-2-microglobulinCancer, 2006
- Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patientsCancer, 1982
- Diagnosis of Leukemia or Lymphoma in the Central Nervous System by Beta2-Microglobulin DeterminationNew England Journal of Medicine, 1980
- Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas findings in a multicenter study and experience in selected patientsCancer, 1980
- Infiltration of central nervous system in adult acute myeloid leukaemia.BMJ, 1979
- The β2-microglobulin content of the cerebrospinal fluid in neurological diseaseJournal of the Neurological Sciences, 1977
- Beta2Microglobulin — Small Molecule — Big Role?New England Journal of Medicine, 1975
- Serum β2-Microglobulin in Renal DiseaseNephron, 1973
- Isolation and Properties of a Low Molecular Weight β2-Globulin Occurring in Human Biological FluidsPublished by Elsevier ,1968
- An analysis of variance test for normality (complete samples)Biometrika, 1965